Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,415.00
Bid: 4,340.00
Ask: 4,420.00
Change: 0.00 (0.00%)
Spread: 80.00 (1.843%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4,415.00
ULVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share purchase programme management share scheme

29 Apr 2019 10:00

RNS Number : 3870X
Unilever PLC
29 April 2019
 

 

Share purchase programme for management share scheme

 

29th April 2019

 

London/Rotterdam - The Unilever Group today announces a programme to purchase shares up to an aggregate market value equivalent of €165 million. The purpose of the programme is to enable the Group to meet share award obligations under its Management Co-Investment Plan. The programme, to be conducted by Unilever N.V., will commence on 29th April 2019 and will end no later than close of business on 17th May 2019.

 

Under the terms of the programme, a maximum of 995,000 Unilever PLC ordinary shares and 1,787,000 Unilever N.V. ordinary shares (or depositary receipts in respect of such ordinary shares) will be purchased.

 

The share purchase programme will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014 and the Commission Delegated Regulation (EU) 2016/1052.

The Group has entered into non-discretionary instructions with UBS AG London Branch to conduct the share purchase programme on its behalf and to make trading decisions under the programme independently of the Group.

 

In addition, up to 81,000 American Depositary Shares of Unilever PLC and up to 891,000 New York Registry Shares of Unilever N.V. will be repurchased for the same purpose on the New York Stock Exchange based on non-discretionary instructions with UBS Securities LLC.

 

Media enquiries

Media Relations UK: +44 7934 483 444 

Media Relations Netherlands: +31 10 217 4844

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

Unilever PLC

 

100 Victoria Embankment

London

EC4Y 0DY

United Kingdom

 

+44 (0) 207 822 5252

Press-Office.London@Unilever.com

 

Unilever NV

 

Weena 455

3013AL

Rotterdam

www.unilever.nl

 

+31 (0) 10 217 4000

mediarelations.rotterdam@Unilever.com

 

 

Safe Harbour

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. Words such as 'will' or the negative of this term and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the "Group"). They are not historical facts, nor are they guarantees of future performance.

 

Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These forward-looking statements speak only as of the date of this announcement. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCILMPTMBATMFL
Date   Source Headline
22nd Jul 20202:42 pmRNSNotice of Separate Adjourned Meetings
22nd Jul 20202:32 pmRNSUnilever Announces Results of Bondholder Meetings
13th Jul 20209:00 amRNSExtension of Early Instruction Deadline
9th Jul 202012:34 pmRNSDirector/PDMR Shareholding
26th Jun 20201:30 pmRNSDIP – Notice of Separate Meetings
26th Jun 20201:15 pmRNSConsent Solicitations
11th Jun 20207:00 amRNSUnification of Unilever’s legal structure
9th Jun 20201:47 pmRNSDirector/PDMR Shareholding
5th Jun 202011:29 amRNSDirector/PDMR Shareholding
12th May 20201:22 pmRNSDirector/PDMR Shareholding
30th Apr 202011:45 amRNSMembership of Board Committees
29th Apr 20204:56 pmRNSDirector/PDMR Shareholding
29th Apr 20203:52 pmRNSResult of AGM
27th Apr 20206:00 pmRNSListing Rule 9.2.6E statement
23rd Apr 20207:00 amRNS1st Quarter 2020 Trading Statement
20th Apr 20205:20 pmRNSUnilever Annual General Meetings update
9th Apr 202011:44 amRNSDirector/PDMR Shareholding
1st Apr 20201:15 pmRNSCompletion of Horlicks acquisition from GSK
30th Mar 202012:30 pmRNSDirector/PDMR Shareholding
24th Mar 20204:43 pmRNSSecond Price Monitoring Extn
24th Mar 20204:37 pmRNSPrice Monitoring Extension
24th Mar 202012:00 pmRNSPublication of Final Terms
24th Mar 202011:00 amRNSHelping to protect lives and livelihoods: Covid-19
23rd Mar 20206:13 pmRNSDirector/PDMR Shareholding
23rd Mar 202012:08 pmRNSSecond Price Monitoring Extn
23rd Mar 202012:03 pmRNSPrice Monitoring Extension
19th Mar 20202:59 pmRNSDirector/PDMR Shareholding
19th Mar 202010:45 amRNSNotice of AGM update
19th Mar 202010:20 amRNSNotice of AGM
13th Mar 20203:45 pmRNSPublication of Suppl.Prospcts
10th Mar 202011:24 amRNSDirector/PDMR Shareholding
10th Mar 20207:30 amRNSAnnual Financial Report
4th Mar 20202:30 pmRNSBoard Composition Announcement
20th Feb 20203:09 pmRNSDirector/PDMR Shareholding
18th Feb 20204:10 pmRNSDirector/PDMR Shareholding
11th Feb 20201:51 pmRNSDirector/PDMR Shareholding
5th Feb 202010:42 amRNSDirector/PDMR Shareholding
30th Jan 20207:00 amRNSFinal Results
10th Jan 202012:08 pmRNSDirector/PDMR Shareholding
17th Dec 20197:00 amRNSUnilever Sales Update
11th Dec 20193:06 pmRNSDirector/PDMR Shareholding
9th Dec 20195:10 pmRNSDirector/PDMR Shareholding
5th Dec 201912:47 pmRNSDirector/PDMR Shareholding
13th Nov 20197:00 amRNSUnilever Chairman announcement
11th Nov 20193:02 pmRNSDirector/PDMR Shareholding
17th Oct 20197:00 amRNS3rd Quarter Trading Statement
10th Oct 20199:17 amRNSDirector/PDMR Shareholding
18th Sep 20192:00 pmRNSTreatment of hyperinflationary countries
16th Sep 20195:42 pmRNSDirector/PDMR Shareholding
12th Sep 20198:40 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.